We're excited to highlight a new review co-authored by TIL Working Group co-chair Dr. Krishna Komanduri in the American Journal of Clinical Dermatology. The publication discusses #TILtherapy innovations and their impact on #melanoma treatment. Read here: bit.ly/441VCb7

Get inspired by this short @BBCStoryWorks documentary on the power of TIL Cell Therapy. Watch the full video and stay informed by checking out the TIL Working Group’s resources here: bit.ly/441VCb7 #TILCellTherapy #Oncology #Research #CellTherapy

Members of the TIL Working Group are excited to be attending @ASCO's annual meeting this week to learn more about the latest in TIL Cell Therapy research. #ASCO25 #TILCellTherapy #CancerResearch #OncTwitter

TIL Working Group is dedicated to improving the lives of those with cancer. Our sponsors are pioneering TIL research and are committed to advancing our common goals and improving patient access and outcomes. Learn more about sponsorship opportunities here: buff.ly/4aYBFDN

Interested in learning more about TIL Cell Therapy? Check out our educational resources on our recently updated website TILWorkingGroup.com to help educate yourself on everything involving #TILCellTherapy and patient care. buff.ly/4hu6Jh7 #ASCO24 #Oncology

This month, we’re celebrating Dr. Marcus Butler in our TIL Working Group spotlight! His insights on #TILcelltherapy help us push boundaries and create impact for people living with cancer. Learn more about our work here: buff.ly/3Z6kSsX #immunotherapy #melanoma

TIL Cell Therapy is revolutionizing cancer treatment! Watch Dr. Amaria explain why she got involved and what’s coming next. Check out the TIL Working Group’s website to watch the full video here: buff.ly/3Ycen7l #TILCellTherapy #CellTherapy #Oncology #Immunotherapy

Curious about the latest in TIL Cell Therapy? 🧬 Our resources keep you informed on groundbreaking advancements and research news. Visit TILWorkingGroup.com to learn more! #CancerResearch #CellTherapy #TILCellTherapy #Oncology #Hematology #ASCO24

Big things are coming for TIL Cell Therapy in 2025! Make sure you visit our website to learn about the latest research efforts here: buff.ly/3Ycen7l #TILCellTherapy #Oncology #Hematology #Research #CellTherapy

We want to extend our gratitude to our bronze sponsor, @KSQ_TX. Our sponsors are pioneers in TIL research and committed to advancing the TIL Working Group’s goals in #PatientCare. Learn more about sponsorship opportunities here: buff.ly/3Z6kSsX #Oncology #TILCellTherapy

We want to extend our gratitude to our gold sponsor, @Obsidian_Tx. Our sponsors are pioneers in TIL research and committed to advancing TIL Working Group’s goals in patient care. Learn more about sponsorship opportunities here: buff.ly/3Z6kSsX #TILCellTherapy #Oncology

We want to extend our gratitude to our founding partner and sponsor @IovanceBio. Our sponsors are pioneers in TIL research and committed to advancing the TIL Working Group's goals in #PatientCare. Learn more about sponsorship opportunities here: buff.ly/3Z6kSsX

In February 2024, the FDA greenlit the first #cellulartherapy to treat solid tumors! Hear @DrBetofMDPhD share her first-hand experience in treating the first patient with the approved therapy here: buff.ly/3Ycen7l #TILCellTherapy #Oncology #CancerResearch #PatientCare

Discover how TIL Cell Therapy is changing lives and advancing cancer treatment. Support our mission by following us for updates and sharing this post to spread awareness! buff.ly/3Ycen7l #TILCellTherapy #CellTherapy #CancerResearch #Education #Oncology #OncTwitter

Your resource for TIL Cell Therapy has arrived! Visit our website to learn more about what's new in TIL Cell Therapy here: buff.ly/3Ycen7l #Oncology #CellTherapy #TILCellTherapy #MedicalNews #Healthcare #OncTwitter

In this insightful recap from #ASCO24, Dr. Sajeve Thomas delves into the treatment of immune checkpoint-naïve patients with advanced melanoma using Lifileucel and Pembrolizumab. Watch now: buff.ly/3Ycen7l #Melanoma #Research #PatientCare #Immunology #Medical #MedTwitter